Steven Gary Richardson

This profile gathers the share dealings of Steven Gary Richardson in Travere Therapeutics, Inc. Over a trading history stretching from 15 August 2013 to 21 November 2014, the count stands at 4 filings.

Purchases make up the whole of the open-market record (3 purchases, €59k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. 2014 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €15k. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +41.2%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 24 November 2014, the filings show an open-market purchase worth €41k in Travere Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.